Cancer cells being destroyed by immunotherapy.
(Source: Adobe Stock)

Discover BioVaxys’ innovative DPX™ platform, a cutting-edge lipid-based delivery system transforming immunotherapy. This video explores how the company’s proprietary technology encapsulates diverse bioactive molecules, enhancing and sustaining immune responses. Learn how BioVaxys is leveraging this groundbreaking platform to potentially revolutionize vaccines and treatments.

To keep up with the latest developments from the company, visit https://www.biovaxys.com/

This is third-party content provided by BioVaxys Technology Corp. (CSE:BIOV). Please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this company on the BioVaxys Technology Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

(Top photo: Adobe Stock)

More From The Market Online
Stock image generated with AI

@ the Bell: TSX ends week reaching another fresh high

Despite mining and tech losses, Canada’s main stock index nudged up on Friday. Industrials was the top gainer on the TSX.
BlaxkBerry logo

BlackBerry AtHoc moves toward FedRAMP high authorization

BlackBerry's (TSX:BB) AtHoc critical event management solution, BlackBerry is listed as in process for federal high authorization.
An artificial intelligence robot and a rising stock chart

Poet Technologies to delist from the TSXV

Poet Technologies (TSXV:PTK) reveals it will delist its shares from the TSXV, but will continue to list its shares on the NASDAQ.